DK0646570T3 - Fremgansmåde til fremstilling af lignanforbindelser - Google Patents

Fremgansmåde til fremstilling af lignanforbindelser

Info

Publication number
DK0646570T3
DK0646570T3 DK94912092T DK94912092T DK0646570T3 DK 0646570 T3 DK0646570 T3 DK 0646570T3 DK 94912092 T DK94912092 T DK 94912092T DK 94912092 T DK94912092 T DK 94912092T DK 0646570 T3 DK0646570 T3 DK 0646570T3
Authority
DK
Denmark
Prior art keywords
compound
general formula
lower alkyl
procedure
preparation
Prior art date
Application number
DK94912092T
Other languages
Danish (da)
English (en)
Inventor
Sachio Mori
Shozo Takechi
Shiro Kida
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK0646570T3 publication Critical patent/DK0646570T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
DK94912092T 1993-04-16 1994-04-12 Fremgansmåde til fremstilling af lignanforbindelser DK0646570T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8994493 1993-04-16
PCT/JP1994/000612 WO1994024087A1 (fr) 1993-04-16 1994-04-12 Procede pour produire un compose de lignane

Publications (1)

Publication Number Publication Date
DK0646570T3 true DK0646570T3 (da) 1998-10-26

Family

ID=13984820

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94912092T DK0646570T3 (da) 1993-04-16 1994-04-12 Fremgansmåde til fremstilling af lignanforbindelser

Country Status (13)

Country Link
US (1) US5488134A (cs)
EP (1) EP0646570B1 (cs)
JP (1) JP3411036B2 (cs)
KR (1) KR100277242B1 (cs)
CN (1) CN1046937C (cs)
AT (1) ATE167662T1 (cs)
AU (1) AU666819B2 (cs)
CA (1) CA2138264C (cs)
DE (1) DE69411243T2 (cs)
DK (1) DK0646570T3 (cs)
ES (1) ES2119190T3 (cs)
TW (1) TW255886B (cs)
WO (1) WO1994024087A1 (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121060C (en) * 1993-04-16 2004-04-06 Sachio Mori Preparation of lignan analogues
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
KR100376281B1 (ko) * 1995-12-26 2003-09-26 에스케이케미칼주식회사 리그난의 제조방법
DE69811930T2 (de) 1997-09-29 2003-12-18 Meiji Seika Kaisha Ltd., Tokio/Tokyo Tricyclische triazolobenzazepinderivate, verfahren zu ihrer herstellung und antiallergische mittel
AU2157500A (en) 1998-12-23 2000-07-31 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
CA2356607A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
EP1140186B1 (en) 1998-12-23 2003-06-04 G.D. Searle LLC. Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
IL143943A0 (en) 1998-12-23 2002-04-21 Searle Llc Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
PL348508A1 (en) 1998-12-23 2002-05-20 Searle Llc Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
AU3103800A (en) 1998-12-23 2000-07-31 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acidderivatives for cardiovascular indications
AU2157400A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
WO2001068096A2 (en) * 2000-03-10 2001-09-20 Pharmacia Corporation Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
WO2001068637A2 (en) 2000-03-10 2001-09-20 Pharmacia Corporation Method for the preparation of tetrahydrobenzothiepines
WO2003040127A1 (en) 2001-11-02 2003-05-15 G.D. Searle Llc Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
MXPA04006255A (es) 2002-01-17 2004-09-27 Pharmacia Corp Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato.
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
EP2995317A1 (en) 2010-05-26 2016-03-16 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
EP3278796A1 (en) 2011-10-28 2018-02-07 Lumena Pharmaceuticals LLC Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
WO2013063512A1 (en) 2011-10-28 2013-05-02 Lumena Pharmaceuticals, Inc Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
US20140271734A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
KR20160002773A (ko) 2013-03-15 2016-01-08 루메나 파마수티컬즈, 인코포레이티드 원발성 담관염 및 염증성 장 질환 치료용 담즙산 재순환 억제제
US20220133738A1 (en) 2019-02-12 2022-05-05 Mirum Pharmaceuticals, Inc. Genotype and dose-dependent response to an asbti in patients with bile salt export pump deficiency

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0372422A (ja) * 1989-05-16 1991-03-27 Tanabe Seiyaku Co Ltd 抗脂血剤
JPH03157351A (ja) * 1989-11-13 1991-07-05 Tanabe Seiyaku Co Ltd ナフタレン誘導体及びその製法
DK0597107T3 (da) * 1991-10-17 1996-07-29 Shionogi & Co Lignananalog, fremstilling deraf og hypolipidæmisk medikament

Also Published As

Publication number Publication date
CN1109685A (zh) 1995-10-04
JP3411036B2 (ja) 2003-05-26
EP0646570A1 (en) 1995-04-05
KR100277242B1 (ko) 2001-02-01
EP0646570B1 (en) 1998-06-24
ATE167662T1 (de) 1998-07-15
CA2138264A1 (en) 1994-10-27
WO1994024087A1 (fr) 1994-10-27
ES2119190T3 (es) 1998-10-01
DE69411243D1 (de) 1998-07-30
US5488134A (en) 1996-01-30
KR950701902A (ko) 1995-05-17
EP0646570A4 (en) 1995-08-09
AU666819B2 (en) 1996-02-22
DE69411243T2 (de) 1998-11-19
TW255886B (cs) 1995-09-01
CN1046937C (zh) 1999-12-01
CA2138264C (en) 2004-04-06
AU6437994A (en) 1994-11-08

Similar Documents

Publication Publication Date Title
DK0646570T3 (da) Fremgansmåde til fremstilling af lignanforbindelser
TW262474B (cs)
AU1120095A (en) Novel imidazole derivative and process for producing the same
ATE161262T1 (de) Optisch aktives zwischenprodukt und dessen herstellung
DK0595111T3 (da) Carbazolonderivater og fremgangsmåde til deres fremstilling
DK0802185T3 (da) Fremgangsmåde til fremstilling af piperidincarbinoler
DK92295A (da) Fremgangsmåde til fremstilling af 1,4-benzoquinoner
AU8460791A (en) Compound, preparation and use
ATE191915T1 (de) Herstellung von borester
EP0601191A4 (en) Novel tetracyclic compound.
HUT53586A (en) Process for producing glutaric acid derivatives
DK0854135T3 (da) Fremgangsmåde til fremstilling af 2-cyanobiphenylforbindelser
AU2124892A (en) A method and intermediates for the preparation of 6-fluorobenzisothiazoles
DE68909143D1 (de) Prostaglandin-Vorläufer und ihre Herstellung.
DK0565059T3 (da) Indolderivat
CA2121060A1 (en) Preparation of lignan analogues
AU4340793A (en) Benzopyran derivative, production thereof, and pharmaceutical preparation containing the same as active ingredient
EP0765866A3 (en) Preparation of optically active (S)-(-) and (R)-(+)- deoxyspergualin and novel intermediates thereof
DK0557519T3 (da) Fremgangsmåde til fremstilling af sulfonamidderivater af norbornan
DE69129605D1 (de) Verfahren zur Herstellung von N-Alkylpyrazolen
MX9800041A (es) Procedimiento mejorado para sintetizar intermediarios de carbapenem.
AU8762491A (en) Process for producing azacycloalkane derivative
KR970042488A (ko) 유기용매를 이용한 아크릴산 에스테르 유도체의 제조방법